| Field | Specification |
|---|---|
| Target | |
| Alternative names | LifLeukemia inhibitory factor ELISA Kit; LIF ELISA Kit; Cholinergic neuronal differentiation factor ELISA Kit |
| UniProt # | |
| Species | |
| Reactivity | |
| Applications | |
| Assay type | |
| Sample type(s) | serum, plasma, bronchoalveolar lavage fluid, tissue homogenates |
| Sensitivity | |
| Detection range | |
| Detection wavelength | |
| Assay time | |
| Catalog no. (Mfr.) | |
| Main SKU |
Background
leukemia inhibitory factor (LIF) is a biological molecule commonly studied in cancer research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
UniProt: P17777
Biological context
Researchers often monitor leukemia inhibitory factor in serum, plasma, bronchoalveolar lavage fluid, and tissue homogenates to better understand themes such as tumor microenvironment biology, cell proliferation and apoptosis, and metastasis and invasion pathways. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in leukemia inhibitory factor may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, cell-cycle regulators, invasion/ECM markers, and immune-oncology mediators) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, leukemia inhibitory factor may also appear under names such as LifLeukemia inhibitory factor and LIF. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that leukemia inhibitory factor participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Menstrual blood-derived mesenchymal stem cells pretreated by low-intensity pulsed ultrasound repair endometrial injury by inhibiting the PI3K/AKT pathway
S Huang, C Cheng, Z Wang, R Li, W Li, K Yu,Reproductive BioMedicine Online,2024
3D Bioprinting a human iPSC-derived MSC-loaded scaffold for repair of the uterine endometrium
W Ji,Acta Biomaterialia,2020
Effect of irisin on endometrial receptivity of rats with polycystic ovary syndrome
Li C, et al,Gynecological Endocrinology,2019
Discovery of Enhancers of the Secretion of Leukemia Inhibitory Factor for the Treatment of Multiple Sclerosis
Vela L.et al,J Biomol Screen.,2016